Cargando…

Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease

Chagas disease is emerging in countries to which it is not endemic. Biomarkers for earlier therapeutic response assessment in patients with chronic Chagas disease are needed. We profiled plasma-derived extracellular vesicles from a heart transplant patient with chronic Chagas disease and showed the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortes-Serra, Nuria, Mendes, Maria Tays, Mazagatos, Clara, Segui-Barber, Joan, Ellis, Cameron C., Ballart, Cristina, Garcia-Alvarez, Ana, Gállego, Montserrat, Gascon, Joaquim, Almeida, Igor C., Pinazo, María Jesús, Fernandez-Becerra, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2020
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392439/ https://www.ncbi.nlm.nih.gov/pubmed/32687028 http://dx.doi.org/10.3201/eid2608.191042

Ejemplares similares

Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2022)

Immunosuppression and Chagas Disease: A Management Challenge
por: Pinazo, María-Jesús, et al.
Publicado: (2013)

Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
por: Martínez-Peinado, Nieves, et al.
Publicado: (2021)

Chagas Disease among the Latin American Adult Population Attending in a Primary Care Center in Barcelona, Spain
por: Roca, Carme, et al.
Publicado: (2011)

Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis
por: Cortes-Serra, Nuria, et al.
Publicado: (2020)

Characterization of digestive disorders of patients with chronic Chagas disease in Cochabamba, Bolivia
por: Pinto, Jimy-Jose, et al.
Publicado: (2019)

Chagas Disease, France
por: Lescure, François-Xavier, et al.
Publicado: (2008)

Acute Chagas Disease Outbreak among Military Personnel, Colombia, 2021
por: Vergara, Hernán Darío, et al.
Publicado: (2023)

Mother-to-Child Transmission of Congenital Chagas Disease, Japan
por: Imai, Kazuo, et al.
Publicado: (2014)

Molecular Epidemiologic Source Tracking of Orally Transmitted Chagas Disease, Venezuela
por: Segovia, Maikell, et al.
Publicado: (2013)

Congenital Transmission of Chagas Disease in Latin American Immigrants in Switzerland
por: Jackson, Yves, et al.
Publicado: (2009)

Acute Chagas Disease Manifesting as Orbital Cellulitis, Texas, USA
por: Hudson, F. Parker, et al.
Publicado: (2021)

Oral Transmission of Chagas Disease by Consumption of Açaí Palm Fruit, Brazil
por: Nóbrega, Aglaêr A., et al.
Publicado: (2009)

Chagas Disease in a Domestic Transmission Cycle in Southern Texas, USA
por: Beard, Charles B., et al.
Publicado: (2003)

Vector Blood Meals and Chagas Disease Transmission Potential, United States
por: Stevens, Lori, et al.
Publicado: (2012)

Triatoma sanguisuga Blood Meals and Potential for Chagas Disease, Louisiana, USA
por: Waleckx, Etienne, et al.
Publicado: (2014)

Deaths Related to Chagas Disease and COVID-19 Co-Infection, Brazil, March–December 2020
por: Martins-Melo, Francisco R., et al.
Publicado: (2022)

Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response
por: Pinazo, Maria-Jesus, et al.
Publicado: (2016)

In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2019)

Chagas Disease Screening in Maternal Donors of Publicly Banked Umbilical Cord Blood, United States
por: Edwards, James M., et al.
Publicado: (2016)

Corrigendum: In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2020)

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
por: Pinazo, Maria-Jesus, et al.
Publicado: (2015)

Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia
por: Pinazo, Maria-Jesus, et al.
Publicado: (2021)

High prevalence of S. Stercoralis infection among patients with Chagas disease: A retrospective case-control study
por: Puerta-Alcalde, Pedro, et al.
Publicado: (2018)

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform
por: Pinazo, Maria-Jesus, et al.
Publicado: (2017)

Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays
por: Abras, Alba, et al.
Publicado: (2018)

CTX-M-15–producing Enteroaggregative Escherichia coli as Cause of Travelers’ Diarrhea
por: Guiral, Elisabet, et al.
Publicado: (2011)

Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network
por: Pinazo, Maria-Jesus, et al.
Publicado: (2022)

Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?
por: Picado, Albert, et al.
Publicado: (2017)

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
por: Martinez-Peinado, Nieves, et al.
Publicado: (2020)

Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis
por: Egüez, Karina E., et al.
Publicado: (2017)

State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
por: Gabaldón-Figueira, Juan Carlos, et al.
Publicado: (2023)

Identification of Trypanosoma cruzi Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021)

Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
por: Garcia-Alvarez, Ana, et al.
Publicado: (2010)

Evaluation of the Performance of the Loopamp Trypanosoma cruzi Detection Kit for the Diagnosis of Chagas Disease in an Area Where It Is Not Endemic, Spain
por: Flores-Chavez, Maria D., et al.
Publicado: (2021)

Use of rapid diagnostic tests (RDTs) for conclusive diagnosis of chronic Chagas disease – field implementation in the Bolivian Chaco region
por: Lozano, Daniel, et al.
Publicado: (2019)

Isoenzymatic characterization of Phlebotomus ariasi and P. perniciosus of canine leishmaniasis foci from Eastern Pyrenean regions and comparison with other populations from Europe
por: Ballart, Cristina, et al.
Publicado: (2018)

Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021)

Zoonotic Onchocerca lupi Infection in Dogs, Greece and Portugal, 2011–2012
por: Otranto, Domenico, et al.
Publicado: (2013)

A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease
por: Montoya, Alba L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ta80nib13duevtqi5f9adddttb